BI
bioAffinity Technologies, Inc.
BIAFW · NASDAQ
$0.15 -16.50% (-$0.03)
1M +78.65%
Market Cap $680.8K
P/E Ratio -
Div. Yield -
ROE 257.27%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.18x
P/S 0.12x
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Op. margin 209.82%
Gross margin 39.57%
FCF margin 194.88%
Quality
10 /100
Poor ROA 199.30%
ROIC 238.03%
Asset turnover 0.77x
Debt
59 /100
Moderate Int. coverage -337.54x
Debt/Equity 0.38x
Current ratio 1.44x
Stability
22 /100
Unstable Profitable years 0
Beta -1.05x
EPS volatility 74.26%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o BIAFW
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Maria Zannes
Employees
57
Headquarters
San Antonio
Nadchodzące wydarzenia
18 LIS
Earnings
Upcoming earnings report